ID

14630

Description

A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02297425

Lien

https://clinicaltrials.gov/show/NCT02297425

Mots-clés

  1. 24/04/2016 24/04/2016 -
Téléchargé le

24 avril 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Advanced EGFRm (Del 19 or L858R +/- T790M) NSCLC NCT02297425

Eligibility Advanced EGFRm (Del 19 or L858R +/- T790M) NSCLC NCT02297425

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
evidence of histological or cytologically confirmed diagnosis of locally advanced or metastatic egfrm (del19 or l858r) nsclc that is resistant to standard therapy. patients must have progressed on treatment with an egfr tki, and may have also received other line of therapy.
Description

EGFR

Type de données

boolean

Alias
UMLS CUI [1]
C0034802
tissue available (formalin fixed paraffin embedded (ffpe) block or 10 unstained sections (5 micron)
Description

tissue available

Type de données

boolean

Alias
UMLS CUI [1]
C2711483
patients must be willing to participate in additional pk studies as required (cohort dependent); patients will be informed of which pk studies are required prior to consenting for study participation
Description

additional pk studies

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
adequate bone marrow function (complete blood count laboratory test results)
Description

bone marrow function

Type de données

boolean

Alias
UMLS CUI [1]
C0005953
adequate liver function (laboratory test)
Description

liver function

Type de données

boolean

Alias
UMLS CUI [1]
C0232741
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previously diagnosed brain metastases, unless the patient has completed their treatment and has recovered from the acute effects of radiation therapy or surgery prior to the study registration, have discontinued corticosteroid treatment for these metastases for at least 2 weeks and are neurologically stable
Description

brain metastases

Type de données

boolean

Alias
UMLS CUI [1]
C0220650
systemic anti-cancer therapy within 4 weeks of starting study treatment excluding egfr tkis. patients on egfr tkis must discontinue the agent for a minimum of 5 days prior to starting study drug
Description

systemic anti-cancer therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0392920
hypertension that cannot be controlled by medication (150/100 mmhg despite optimal medical therapy).
Description

hypertension

Type de données

boolean

Alias
UMLS CUI [1]
C0020538

Similar models

Eligibility Advanced EGFRm (Del 19 or L858R +/- T790M) NSCLC NCT02297425

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
EGFR
Item
evidence of histological or cytologically confirmed diagnosis of locally advanced or metastatic egfrm (del19 or l858r) nsclc that is resistant to standard therapy. patients must have progressed on treatment with an egfr tki, and may have also received other line of therapy.
boolean
C0034802 (UMLS CUI [1])
tissue available
Item
tissue available (formalin fixed paraffin embedded (ffpe) block or 10 unstained sections (5 micron)
boolean
C2711483 (UMLS CUI [1])
additional pk studies
Item
patients must be willing to participate in additional pk studies as required (cohort dependent); patients will be informed of which pk studies are required prior to consenting for study participation
boolean
C2348568 (UMLS CUI [1])
bone marrow function
Item
adequate bone marrow function (complete blood count laboratory test results)
boolean
C0005953 (UMLS CUI [1])
liver function
Item
adequate liver function (laboratory test)
boolean
C0232741 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
brain metastases
Item
previously diagnosed brain metastases, unless the patient has completed their treatment and has recovered from the acute effects of radiation therapy or surgery prior to the study registration, have discontinued corticosteroid treatment for these metastases for at least 2 weeks and are neurologically stable
boolean
C0220650 (UMLS CUI [1])
systemic anti-cancer therapy
Item
systemic anti-cancer therapy within 4 weeks of starting study treatment excluding egfr tkis. patients on egfr tkis must discontinue the agent for a minimum of 5 days prior to starting study drug
boolean
C0392920 (UMLS CUI [1])
hypertension
Item
hypertension that cannot be controlled by medication (150/100 mmhg despite optimal medical therapy).
boolean
C0020538 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial